Brexit - Addressing the Regulatory Impact on Pharma & Life Sciences Industry

Logo
Presented by

Prajeesh Pillai, Pharmaceutical & Life Sciences Solutions Lead

About this talk

With MHRA releasing the new post-Brexit transition guidelines, pharmaceutical, and life sciences businesses will need to adopt and implement changes to continue their operations in the UK. These changes are bound to add the resource, cost, and time burden on the manufacturers. ​ ​ Preparing and priming processes to seamlessly adopt the new guidelines would help businesses meet regulatory requirements with certainty and confidence.​ ​Attend this webinar to learn about​ -The impact of new MHRA guidelines​ -Assessment of process preparedness​ -Optimization of change implementation​ -Technology interventions in regulatory operations. ​

Related topics:

More from this channel

Upcoming talks (0)
On-demand talks (33)
Subscribers (506)
Tata Elxsi is amongst the world’s leading providers of design and technology services across industries including Automotive, Broadcast, Communications, Healthcare, and Transportation. Tata Elxsi is helping customers reimagine their products and services through design thinking and the application of digital technologies such as IoT (Internet of Things), Cloud, Mobility, Virtual Reality, and Artificial Intelligence.